Assessment of effectiveness of Vata anulomana Yavagu in the management of Vibandha

The effectiveness of Vatanulomana Yavagu in the management of Vibandha - a single arm study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070539

Enrollment

158

Registered

2024-07-12

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling rome IV criteria

Exclusion criteria

Exclusion criteria: 1)Patients with systemic diseases Systemic disease – diabetes , hypercalcemia , hypothyroidisim, multiple sclerosis , spinal cord lesion , cerebrovascular accidents , parkisonism , hirschsprung’s disease . 2)Pregnant and lactating mothers 3)Patients undergoing any drug therapy. 4)Patient with severe Comorbidities (Renal disease, Hepatic Disease, IHD, CABG). 5)Patients with vibandh because of Obstructive pathology. 6)Colon and Rectal CA.

Design outcomes

Primary

Measure	Time frame
Vatanulomana Yavagu is effective in managing vibandh.Timepoint: 1st assessment- 1st day 2nd assessment- 8th day 3rd assessment- 15th day	—

Secondary

Measure	Time frame
Vatanulomana yavagu can be used as a medicated diet in patients of vibandh.Timepoint: 1st assessment- 1st day 2nd assessment- 8th day 3rd assessment- 15th day	—

Countries

India

Contacts

Public ContactDR UNNIKRISHNAN S

Chaudhary Brahm Prakash Ayurved Charak Sansthan

monikarohillad@gmail.com7827477977

Outcome results